IPOGrid
0001939365
Company

INSPIRE VETERINARY PARTNERS, INC.

Agricultural Services · IVPR

follow-on trading priced OTC 424B3

Filing Timeline

SEC EDGAR
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2026-01-30 · 0001213900-26-010238
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2026-01-29 · 9999999995-26-000350
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2026-01-28 · 0001213900-26-008852
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2026-01-16 · 0001213900-26-005149
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
46,419,092 shares
Class A · Exchange Nasdaq Capital Market · Ticker IVP · Warrants exercisable at $1.00 per share · Selling stockholders only · Use of proceeds Proceeds will be received by the selling stockholders, with no proceeds to the company · Underwriters self-underwritten
2025-12-09 · 0001213900-25-119723
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-12-09 · 9999999995-25-003603
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
46,419,092 shares
Class A · Exchange Nasdaq Capital Market · Ticker IVP · 7,725,000 warrants exercisable at $1.00 per share · Selling stockholders only · Use of proceeds The company will not receive any proceeds from the sale of the common stock by the selling stockholders · Underwriters self-underwritten
2025-12-05 · 0001213900-25-118818
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2025-10-06 · 0001213900-25-096235
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2025-10-03 · 0001213900-25-096093
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2025-09-26 · 9999999995-25-003124
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
2025-09-19 · 0001213900-25-089530
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1 and ends the active registration process.
2025-07-30 · 0001213900-25-069208
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
Price $1.52 · 3,289,473 shares
Class A · Exchange Nasdaq · Ticker IVP · Each Unit consists of one share of Class A Common Stock, one Pre-Funded Warrant, and one Warrant · Warrants exercisable at $[ ] per share for five years · Flags units, warrants
2025-07-08 · 0001213900-25-061867
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B5.
2025-06-20 · 0001213900-25-056027
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $1.83 · 207,896 shares · Gross proceeds $2,000,000
Class A · Exchange Nasdaq · Ticker IVP · Series A and B Warrants to purchase up to 1,092,896 shares each · Use of proceeds General corporate purposes · Flags warrants · Underwriters D. Boral Capital LLC
2025-03-26 · 0001013762-25-002532
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2024-12-23 · 0001213900-24-111433
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $0.25 · 1,800,000 shares · Gross proceeds $2,500,000
A · Exchange Nasdaq · Ticker IVP · Pre-funded warrants to purchase 8,200,000 shares at $0.001 exercise price · Use of proceeds Working capital, general corporate purposes, and potential acquisitions · Underwriters Spartan Capital Securities, LLC
2024-10-22 · 0001213900-24-089703
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2024-10-11 · 9999999995-24-003171
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $1.00 · 6,000,000 shares · Gross proceeds $6,000,000
Class A · Exchange Nasdaq · Ticker IVP · Each Unit consists of one share of Class A Common Stock and one Warrant to purchase one share of Class A Common Stock · Warrants exercisable at $1.00 per share for six months · Use of proceeds for general working capital · Flags units, warrants, best_efforts · Underwriters Spartan Capital Securities, LLC
2024-07-09 · 0001213900-24-060011
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2024-07-02 · 9999999995-24-002057
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2024-07-01 · 0001213900-24-057588
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2024-06-26 · 0001213900-24-055861
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2024-06-24 · 0001213900-24-054921
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2024-06-14 · 0001213900-24-052574
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
2024-05-10 · 0001213900-24-041702
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2024-02-16 · 0001213900-24-014663
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows S-1/A and confirms the priced prospectus.
Price $0.09 · 2,859,894 shares · Gross proceeds $4,000,000
Class A · Exchange Nasdaq · Ticker IVP · Pre-Funded Warrants to purchase 44,198,929 shares of Class A Common Stock at $0.0001 per share · Use of proceeds for general working capital · Underwriters Spartan Capital Securities, LLC
2024-02-13 · 0001213900-24-012825
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2024-02-13 · 9999999995-24-000426
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior EFFECT filing.
2024-02-09 · 0001213900-24-011830
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2024-02-08 · 9999999995-24-000354
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1/A in the pre-IPO sequence.
7,869,182 shares
Class A · Exchange Nasdaq · Ticker IVP · Pre-funded warrant for up to 2,869,182 shares · Selling stockholders only · Use of proceeds Proceeds from the resale by Tumim are not received by the company; potential future proceeds from the Purchase Agreement up to $30.0 million · Flags warrants · Underwriters Tumim Stone Capital LLC
2024-01-31 · 0001213900-24-008487
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $0.19 · 26,581,605 shares · Gross proceeds $5,000,000
Class A · Exchange Nasdaq · Ticker IVP · Pre-funded warrants to purchase up to 26,581,605 shares of Class A Common Stock, exercisable at $0.0001 per share · Use of proceeds General working capital · Flags best_efforts · Underwriters Spartan Capital Securities, LLC
2024-01-26 · 0001213900-24-006983
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B4 in the pre-IPO sequence.
2024-01-04 · 0001213900-24-001218
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-08-31 · 0001575872-23-001384
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2023-08-29 · 0001354457-23-000609
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows CERT and registers the class of securities for exchange listing.
2023-08-29 · 0001575872-23-001373
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2023-08-29 · 9999999995-23-002519
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 6,375,266 shares of Class A common stock, including 1,600,000 shares sold by the company and 4,775,266 shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds expected to be used for general corporate purposes. The company operates veterinary hospitals in the U.S., specializing in small animal care and expanding through acquisitions. The IPO is underwritten by SpartanCapital Securities, LLC, with shares tentatively listed on Nasdaq under the ticker IVP.
2023-08-23 · 0001575872-23-001347
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 6,375,266 shares of Class A common stock, including 1,600,000 shares offered by the company and up to 4,775,266 shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds intended for general corporate purposes. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions. The IPO is underwritten by Spartan Capital Securities, LLC, with the listing on Nasdaq contingent on successful execution.
2023-08-17 · 0001575872-23-001334
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 6,247,915 shares of Class A common stock, including 1,500,000 shares sold by the company and 4,747,915 shares by selling stockholders. The offering is underwritten by Spartan Capital Securities, LLC, with a public price of $5.00 per share. The company operates veterinary hospitals in the U.S., specializing in small animal care and expanding through acquisitions. The IPO aims to raise proceeds for general corporate purposes, with shares subject to market conditions and Nasdaq listing eligibility.
2023-08-08 · 0001575872-23-001288
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 6,247,915 shares of Class A common stock, including 1,500,000 shares offered by the company and 4,747,915 shares by selling stockholders. The public offering price is set at $5.00 per share, with proceeds intended for general corporate purposes. The offering is contingent on the successful completion of the primary underwritten offering, and shares are subject to resale under a registration statement. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions.
2023-08-04 · 0001575872-23-001279
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 6,247,915 shares of Class A common stock, including 1.5 million shares sold by the company and 4.7 million shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds from the company's shares intended for general corporate purposes. The IPO includes shares from convertible debentures, warrants, and preferred stock conversions. The company plans to list on Nasdaq under the symbol IVP, though no assurance of listing is provided. The offering is contingent on the success of the primary underwritten offering, and selling stockholders may resell shares over 180 days post-filing.
2023-08-04 · 0001575872-23-001281
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) to raise capital through the sale of 1,500,000 Class A common shares and up to 4,747,915 shares from selling stockholders. The offering aims to expand its network of veterinary hospitals through acquisitions, with a focus on small animal care and specialty services. The company plans to list on Nasdaq under the symbol IVP, though listing is contingent on the IPO's success. The offering includes shares from convertible securities and warrants, with proceeds intended for growth and operational needs.
2023-08-02 · 0001575872-23-001267
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,747,915 shares of Class A common stock, including 1,000,000 shares sold by the company and 4,747,915 shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds to the company estimated at $4.60 per share after underwriting discounts. The IPO is underwritten by Spartan Capital Securities, LLC, and the shares are intended for listing on the Nasdaq Capital Market, though no assurance is provided. The offering includes potential conversions of preferred stock, convertible debentures, and warrants, which could affect voting power and dilution.
2023-07-27 · 0001575872-23-001234
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,747,915 shares of Class A common stock, including 1,000,000 shares sold by the company and up to 4,747,915 shares by selling stockholders. The offering is underwritten by Spartan Capital Securities, LLC, with a public offering price of $5.00 per share. The company plans to list on Nasdaq under the symbol IVP, though no assurance is given. The IPO is conditioned on the successful completion of the primary offering, and proceeds will be used for general corporate purposes.
2023-07-17 · 0001575872-23-001162
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,686,747 shares of Class A common stock, including 1,000,000 shares sold by the company and 4,686,747 shares by selling stockholders. The offering price is $5.00 per share, with proceeds to the company estimated at $4.60 per share after underwriting discounts. The company plans to list on Nasdaq under the symbol IVP, though no assurance is given. The sale of selling stockholder shares is contingent on the success of the primary offering. The company operates 13 veterinary hospitals across nine states and expands via acquisitions.
2023-06-16 · 0001575872-23-000986
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,686,747 shares of Class A common stock, including 1,000,000 shares offered by the company and 4,686,747 shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds intended for general corporate purposes. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions. The IPO follows a reorganization from Delaware to Nevada and includes a dual-class share structure with Class B shares carrying 25 votes per share.
2023-05-23 · 0001575872-23-000821
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,624,839 shares of Class A common stock, including 1,000,000 shares sold by the company and up to 4,624,839 shares by selling stockholders. The offering is underwritten by Spartan Capital Securities, LLC, with a public price of $5.00 per share. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions. The IPO aims to list shares on Nasdaq under the symbol IVP, though no assurance of listing is provided. Risks include dependence on key personnel, competition, and the success of the offering.
2023-04-25 · 0001575872-23-000622
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 5,612,839 shares of Class A common stock, including 1,000,000 shares offered by the company and 4,612,839 shares by selling stockholders. The offering includes shares from convertible debt, warrants, and Class B stock conversions. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions. The IPO is conditioned on the successful completion of the primary offering, with shares potentially listed on Nasdaq under the ticker IVP.
2023-04-07 · 0001575872-23-000540
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 10,853,632 shares of Class A common stock, including 2,000,000 shares offered by the company and 8,853,632 shares by selling stockholders. The offering price is set at $5.00 per share, with proceeds intended for general corporate purposes. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions. The IPO is conditional on a Nasdaq listing, and the capital structure includes Class A (5.7% voting) and Class B (94.3% voting) shares, with Class B convertible to Class A.
2023-02-02 · 0001575872-23-000197
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to 27,454,567 shares of Class A common stock, including 2,000,000 shares sold by the company and 25,454,567 shares by selling stockholders. The offering is underwritten by Spartan Capital Securities, LLC, with a proposed listing on Nasdaq under the symbol IVP. The company operates 13 veterinary hospitals across 9 states and plans to expand through acquisitions, including its first Northeast acquisition in 2022. The IPO is contingent on the success of the primary offering, and the company emphasizes its focus on small animal care with expanding services.
2023-01-30 · 0001575872-23-000175
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of up to shares of Class A common stock, with the Company selling shares on a firm commitment underwritten basis and Selling Stockholders reselling up to shares. The offering is conditioned on the successful completion of the primary offering, and the Company plans to list its Class A common stock on the Nasdaq Capital Market under the symbol IVP. The filing highlights the company's expansion strategy through acquisitions and its focus on veterinary care services, including preventive care, surgery, and specialty services.
2023-01-05 · 0001575872-23-000020
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of its Class A common stock, with shares to be sold by both the company and selling stockholders. The offering includes a firm commitment underwriting by Spartan Capital Securities, LLC, and the stock is proposed to be listed on the Nasdaq Capital Market. The filing outlines the structure of the offering, including price ranges, underwriting discounts, and the conversion rights of Class B shares. The company operates veterinary hospitals in the U.S., focusing on small animal care and expanding through acquisitions.
2022-12-08 · 0001575872-22-001276
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Inspire Veterinary Partners, Inc. is conducting an initial public offering (IPO) of its Class A common stock, with the filing submitted confidentially under Form S-1. The company operates veterinary hospitals in the U.S., specializing in small animal care and expanding through acquisitions. It has a dual-class share structure, with Class B shares holding significant voting power. The offering includes up to 780 Lynnhaven Parkway, Virginia Beach, VA 23452, and the lead underwriter is Spartan Capital Securities, LLC. The filing highlights growth strategies, market opportunities in the pet care industry, and risks related to acquisitions and regulatory changes.
2022-10-25 · 0001575872-22-001025
Comparable Deals
Not enough completed IPOs with similar characteristics to show comparables yet.

Recent News

No recent news stored for this issuer.